News
Sun Pharma has discontinued the development of SCD-044 after Phase 2 trials failed to meet primary goals in treating ...
Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback